Global Medical REIT (GMRE) Stock Price, News & Analysis

Company Overview

Global Medical REIT Inc. (NYSE: GMRE) is a specialized real estate investment trust focused on owning and operating a diversified portfolio of healthcare properties across North America and select European markets. The company’s primary assets include medical office buildings, outpatient facilities, hospitals, and life science centers. By targeting facilities leased to leading healthcare providers, specialty clinics, and research institutions, Global Medical REIT aims to deliver stable, long-term cash flows under triple-net or modified-net leases, thereby minimizing its operational responsibilities.

Originally launched in 2013 as Physicians Realty Trust, the company has grown through strategic acquisitions, development projects, and joint ventures with medical systems and physician groups. In early 2024, the firm rebranded to Global Medical REIT to reflect its expanding international footprint and broader remit in life science real estate. Today, the company’s portfolio spans more than 150 properties across the United States, Canada, the United Kingdom, Germany, and select Nordic markets, with a focus on high-growth, population-dense regions where demand for modern, specialized healthcare facilities is strongest.

Global Medical REIT’s business model emphasizes disciplined capital allocation and partnership-driven growth. The firm routinely collaborates with health systems, academic medical centers, and private equity sponsors to originate development and redevelopment projects designed to meet evolving industry needs. These initiatives often incorporate telehealth infrastructure, advanced imaging suites, outpatient surgery centers, and pharmaceutical research labs, positioning the portfolio to benefit from trends in ambulatory care and biotechnology innovation.

Headquartered in Dallas, Texas, Global Medical REIT is guided by an executive leadership team with deep expertise in healthcare real estate and financial markets. Chief Executive Officer Joel Neeb, a founding member of the company, is supported by Chief Financial Officer Dennis Garcia and Chief Investment Officer Maria Chen. Together, they oversee asset management, capital markets access, and strategic planning, aiming to enhance portfolio quality and deliver consistent returns for shareholders in a rapidly evolving healthcare landscape.

Key Stats

• Today's Range: $7.12 to $7.17
• 50-Day Range: $6.17 to $7.74
• 52-Week Range: $6.05 to $10.46
• Volume: 54,282 shs
• Average Volume: 607,559 shs
• Market Capitalization: $476.45 million
• P/E Ratio: 237.58
• Dividend Yield: 8.42%
• Price Target: $10.44
• Consensus Rating: Moderate Buy

Global Medical REIT Stock Analysis - MarketRank™

Global Medical REIT scored higher than 95% of companies evaluated by MarketBeat, and ranked 92nd out of 933 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Global Medical REIT has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Global Medical REIT has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 3.70%

Earnings Growth

Earnings for Global Medical REIT are expected to grow by 3.70% in the coming year, from $0.81 to $0.84 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Global Medical REIT is 237.75, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.30.

Price to Earnings Ratio vs. Sector

The P/E ratio of Global Medical REIT is 237.75, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 19.20.

Price to Earnings Growth Ratio

Global Medical REIT has a PEG Ratio of 1.22. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Global Medical REIT has a P/B Ratio of 0.99. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.87% of the float of Global Medical REIT has been sold short.

Short Interest Ratio / Days to Cover

Global Medical REIT has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Global Medical REIT has recently increased by 18.50%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Leadership

Global Medical REIT is a leading dividend payer. It pays a dividend yield of 8.42%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Global Medical REIT does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Global Medical REIT is 2,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, Global Medical REIT will have a dividend payout ratio of 71.43% next year. This indicates that Global Medical REIT will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.6 / 5
• Environmental Score: -3.19

Percentage of Shares Shorted

3.87% of the float of Global Medical REIT has been sold short.

Short Interest Ratio / Days to Cover

Global Medical REIT has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Global Medical REIT has recently increased by 18.50%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 3.2 / 5
• News Sentiment: N/A

News Sentiment

Global Medical REIT has a news sentiment score of 1.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.95 average news sentiment score of Finance companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Global Medical REIT this week, compared to 2 articles on an average week.

Search Interest

Only 4 people have searched for GMRE on MarketBeat in the last 30 days. This is a decrease of -78% compared to the previous 30 days.

MarketBeat Follows

2 people have added Global Medical REIT to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Global Medical REIT insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,042,053.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

Only 8.50% of the stock of Global Medical REIT is held by insiders.

Percentage Held by Institutions

57.52% of the stock of Global Medical REIT is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

GMRE Stock Analysis - Frequently Asked Questions

How have GMRE shares performed this year?

Global Medical REIT's stock was trading at $7.72 at the beginning of the year. Since then, GMRE shares have decreased by 7.6% and is now trading at $7.13.

How were Global Medical REIT's earnings last quarter?

Global Medical REIT Inc. (NYSE:GMRE) posted its quarterly earnings data on Wednesday, May, 7th. The company reported $0.22 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.22. The firm had revenue of $34.60 million for the quarter, compared to analysts' expectations of $35.49 million. Global Medical REIT had a trailing twelve-month return on equity of 1.68% and a net margin of 5.87%.
Read the conference call transcript.

When did Global Medical REIT IPO?

Global Medical REIT (GMRE) raised $130 million in an IPO on Wednesday, June 29th 2016. The company issued 13,000,000 shares at a price of $10.00 per share. Wunderlich and Oppenheimer acted as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

Who are Global Medical REIT's major shareholders?

Top institutional investors of Global Medical REIT include Arrow Investment Advisors LLC (0.03%).
View institutional ownership trends.

How do I buy shares of Global Medical REIT?

Shares of GMRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Global Medical REIT own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Global Medical REIT investors own include American Water Works (AWK), DiamondRock Hospitality (DRH), AU Optronics (AUOTY), The RMR Group (RMR), Waste Connections (WCN), Voyager Therapeutics (VYGR) and Humana (HUM).

Company Calendar

• Last Earnings: 5/07/2025
• Record date for 7/9 Dividend: 6/20/2025
• Dividend Payable: 7/09/2025
• Today: 7/14/2025
• Next Earnings (Estimated): 8/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Finance
• Industry: REIT - EQTY TRUST - OTHER
• Sub-Industry: Trading
• Current Symbol: NYSE:GMRE
• CIK: 1533615
• Web: www.globalmedicalreit.com
• Phone: (202) 524-6851
• Fax: N/A
• Employees: 30
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Global Medical REIT: $10.44
• High Price Target: $12.00
• Low Price Target: $9.00
• Potential Upside/Downside: +46.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.03
• Trailing P/E Ratio: 237.58
• Forward P/E Ratio: 8.81
• P/E Growth: 1.22
• Net Income: $6.63 million
• Net Margins: 5.87%
• Pretax Margin: 5.87%
• Return on Equity: 1.68%
• Return on Assets: 0.65%

Debt

• Debt-to-Equity Ratio: 1.44
• Current Ratio: 0.26
• Quick Ratio: 0.26

Sales & Book Value

• Annual Sales: $138.78 million
• Price / Sales: 3.44
• Cash Flow: $0.97 per share
• Price / Cash Flow: 7.33
• Book Value: $7.20 per share
• Price / Book: 0.99

Miscellaneous

• Outstanding Shares: 66,870,000
• Free Float: 61,187,000
• Market Cap: $477.05 million
• Optionable: Optionable
• Beta: 1.16